MedTrace Logo

Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.

NCT03979222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1205

Last updated 2019-08-20

No results posted yet for this study

Summary

This is an observational study of outcomes of the NHS England-commissioned national respiratory ECMO service, which has been active at six centres since December 2011.

The primary outcome of interest is the number of patients who survive to ICU discharge at the ECMO centre. The study also aims to identify factors predictive of outcome.

Conditions

  • Acute Respiratory Failure

Interventions

DEVICE

Extracorporeal Membrane Oxygenation

ECMO provides extracorporeal gas exchange through use of a membrane oxygenator. Blood is drained from a central vein and returned after oxygenation into either the venous or arterial circulation dependent on configuration.

Sponsors & Collaborators

  • Royal Papworth Hospital Clinical Trials Unit

    collaborator UNKNOWN

  • Aberdeen Royal Infirmary, NHS Grampian

    collaborator UNKNOWN

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER

  • Royal Brompton & Harefield Hospitals NHS Foundation Trust

    collaborator UNKNOWN

  • Royal Papworth Hospital NHS Foundation Trust

    collaborator UNKNOWN

  • University Hospitals of Leicester NHS Foundation Trust

    collaborator UNKNOWN

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV

  • NHS England

    collaborator OTHER_GOV

  • University of Cambridge

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-01
Primary Completion
2018-03-31
Completion
2018-03-31
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03979222 on ClinicalTrials.gov